UBER DIE BEEINFLUSSING DER AKUTEN TOXIZITAT DES PROTOVERATRIN A

[1] FERNANDEZ E, 1955, Arch Int Pharmacodyn Ther, V100, P425

[2] FROMMEL E, 1962, MED EXP, V6, P261

[3] HAPKE HJ, 1961, ARCH INT PHARMACOD T, V134, P454

[4] Krayer O, 1944, J PHARMACOL EXP THER, V82, P167

[5] MARTINI L, 1955, Arch Int Pharmacodyn Ther, V101, P49

[6] Mendez R, 1943, J PHARMACOL EXP THER, V78, P238

[7] MOSEY L, 1952, J PHARMACOL EXP THER, V104, P67

[8] SCHOETENSACK W, 1964, Arzneimittelforschung, V14, P428

[9] SWISS ED, 1952, J PHARMACOL EXP THER, V105, P87

[10] SWISS ED, 1961, P SOC EXP BIOL NY, V76, P847

[1] FERNANDEZ E, 1955, Arch Int Pharmacodyn Ther, V100, P425

[2] FROMMEL E, 1962, MED EXP, V6, P261

[3] HAPKE HJ, 1961, ARCH INT PHARMACOD T, V134, P454

[4] Krayer O, 1944, J PHARMACOL EXP THER, V82, P167

[5] MARTINI L, 1955, Arch Int Pharmacodyn Ther, V101, P49

[6] Mendez R, 1943, J PHARMACOL EXP THER, V78, P238

[7] MOSEY L, 1952, J PHARMACOL EXP THER, V104, P67

[8] SCHOETENSACK W, 1964, Arzneimittelforschung, V14, P428

[9] SWISS ED, 1952, J PHARMACOL EXP THER, V105, P87

[10] SWISS ED, 1961, P SOC EXP BIOL NY, V76, P847